2.68
2.68 (-6.01%)
As of Jun 14, 2022
Bioatla, Inc. [BCAB]
Source:
Company Overview
Bioatla, Inc is a clinical-stage biopharmaceutical company developing our novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | 858-558-0708 |
| Industry | |
| CEO | Jay M. Short, Ph.D. |
| Website | www.bioatla.com |